– Phase 1, Syndex Bio have moved in with 10,301 of fitted lab and office space available for immediate occupation – Phase 2, ‘The Briggs’ our 55,000 sq ft new-build lab and office achieved Practical Completion – Phase 3, our 21,500 sq ft single storey R&D units under construction All within a 5 minute walk […]
The Mission Street team were delighted to co-host Nucleome Therapeutics‘s opening event at Inventa. The event was well attended by the wider Oxford life science and tech ecosystem. Great to see Nucleome Therapeutics settled in and thriving at their new home! We look forward to welcoming other tenants imminently to Inventa with more news coming soon. Watch […]
Tristan Capital Partners’ debt fund has refinanced a £310m prime life science portfolio located across Cambridge and Oxford, Green Street News can reveal. Tristan has issued a senior £180m loan – which has been funded by its TIPS One Debt Fund and a co-investment partner – to sponsor BGO and its joint venture partner Mission […]
Mission Street was honoured to host Sarah Haywood, MD at Advanced Oxford, for the launch of their Green Paper on Growing & Diversifying Equity Investment in Oxfordshire at Inventa . The green paper can be accessed in the research section of the Advanced Oxford’s website https://www.advancedoxford.com/latest-research/
The Creative Disruption Forums (CDFs), hosted by Prof. Tony Sedgwick and Graham Combe, have been shaping thought leadership through in-person and virtual events for the past eight years. Since their launch on 22 May 2024 in London, CDFs have been held in Cambridge on 13 June and Oxford on 10 July, with the event at […]
